[CT纹理分析用于预测PD-1抑制剂治疗期间转移性清细胞脏细胞癌的伪进展]
B J Zheng1, W J Xu1, L D Zhao2
1Department of Radiology, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China.
Zhonghua nei ke za zhi
|August 31, 2023
概括
增强的CT纹理分析可以预测转移性清细胞细胞癌 (mccRCC) 患者的伪进展,这些患者接受了编程细胞死亡蛋白1 (PD-1) 抑制剂的治疗. 一个开发的模型显示了高准确度,有助于评估治疗反应.
科学领域:
- 放射学和成像学 放射学和成像学
- 在瘤学瘤学.
- 医学物理 医学物理
更多相关视频
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
33.6K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.6K
